Eltrombopag NOBEL 12.5 mg

Eltrombopag NOBEL 12.5 mg is a medicine authorised by Swissmedic under authorisation number 69450. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 August 2024 and the authorisation is limited until 27 August 2029. ATC code B02BX05 places the medicine in the group Antihemorrhagics.

  • Dispensing category A
  • Authorisation number 69450
  • ATC B02BX05
  • Synthetic medicines
Authorisation data
Authorisation number69450
NameEltrombopag NOBEL 12.5 mg
Full nameEltrombopag NOBEL 12.5 mg, Filmtabletten
Authorisation holderNOBEL Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeB02BX05
First authorisation28 August 2024
Authorisation validity27 August 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Eltrombopag NOBEL 12.5 mg, FilmtablettenA28 August 2024
2Eltrombopag NOBEL 25 mg, FilmtablettenA28 August 2024
3Eltrombopag NOBEL 50 mg, FilmtablettenA28 August 2024
4Eltrombopag NOBEL 75 mg, FilmtablettenA28 August 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
114Tablette(n)B02BX0506.99.0.A
214Tablette(n)B02BX0506.99.0.A
328Tablette(n)B02BX0506.99.0.A
414Tablette(n)B02BX0506.99.0.A
528Tablette(n)B02BX0506.99.0.A
628Tablette(n)B02BX0506.99.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Eltrombopag NOBEL 12.5 mg authorised in Switzerland?

Yes. Eltrombopag NOBEL 12.5 mg is authorised by Swissmedic under authorisation number 69450, data as of 01 September 2026. The authorisation is limited until 27 August 2029.

Which dispensing category does Eltrombopag NOBEL 12.5 mg have?

Eltrombopag NOBEL 12.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Eltrombopag NOBEL 12.5 mg?

The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com